Atlantic American Corp

Aktienanalyse zu Atlantic American Corp (AAME)

$1.450

+0.552 (+38.10%)Zum Schluss

Loading chart…
Hoch
1.560
Eröffnung
1.400
Volumengewichteter Durchschnittskurs
1.40
Volumen
48.57M
Marktkap.
35.09M
Tief
1.185
Umsatz
67.92M
EV/EBITDA, TTM
0.00

Atlantic American Corporation is an insurance holding company involved, through its subsidiary companies, in specialty markets of the life, health, and property and casualty insurance industries. The Company’s principal insurance subsidiaries are American Southern Insurance Company and American Safety Insurance Company (American Southern) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (Bankers Fidelity) within the life and health insurance industry. American Southern's primary product lines include commercial automobile insurance, general liability insurance, and surety bonds. Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplements and other accident and health insurance products.

www.atlam.com

KI-Analyse of Atlantic American Corp (AAME)

Verkaufen

Given the current price of $1.05 and a significant year-to-date change of -63.54%, the stock is not a good buy right now. The RSI is extremely low at 7.485, indicating oversold conditions, but the ongoing compliance issues with Nasdaq and the negative performance trends suggest further risks.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Atlantic American Corp (AAME) beträgt 7.39, verglichen mit dem 5-Jahres-Durchschnitt von 1.18.

Erwartetes KGV

Stark überbewertet
5J-Durchschnitt P/E
1.18
Aktuelles P/E
7.39
Überbewertet
3.84
Unterbewertet
-1.48

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
0.00
Aktuelles P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio-AI-Kursszenarien für AAME

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%AAME

$2.86

Szenariopreis

B

Basis

Basis · 50%AAME

$2.63

Szenariopreis

B

Bärisch

Bärisch · 25%AAME

$2.18

Szenariopreis

AAME FAQ – beantwortet von Alphio AI

Atlantic American Corporation is an insurance holding company involved, through its subsidiary companies, in specialty markets of the life, health, and property and casualty insurance industries. The Company’s principal insurance subsidiaries are American Southern Insurance Company and American Safety Insurance Company (American Southern) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (Bankers Fidelity) within the life and health insurance industry. American Southern's primary product lines include commercial automobile insurance, general liability insurance, and surety bonds. Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life insurance, Medicare supplements and other accident and health insurance products. It operates in the Financials sector (LIFE INSURANCE industry).

Given the current price of $1.05 and a significant year-to-date change of -63.54%, the stock is not a good buy right now. The RSI is extremely low at 7.485, indicating oversold conditions, but the ongoing compliance issues with Nasdaq and the negative performance trends suggest further risks.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln